These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
736 related articles for article (PubMed ID: 25921702)
21. Design, synthesis, molecular docking, and anticancer activity of benzoxazole derivatives as VEGFR-2 inhibitors. El-Helby AA; Sakr H; Eissa IH; Abulkhair H; Al-Karmalawy AA; El-Adl K Arch Pharm (Weinheim); 2019 Oct; 352(10):e1900113. PubMed ID: 31448458 [TBL] [Abstract][Full Text] [Related]
22. Design and synthesis of new 1,6-dihydropyrimidin-2-thio derivatives targeting VEGFR-2: Molecular docking and antiproliferative evaluation. Marzouk AA; Abdel-Aziz SA; Abdelrahman KS; Wanas AS; Gouda AM; Youssif BGM; Abdel-Aziz M Bioorg Chem; 2020 Sep; 102():104090. PubMed ID: 32683176 [TBL] [Abstract][Full Text] [Related]
23. Design, synthesis and in vitro anti-proliferative activity of 4,6-quinazolinediamines as potent EGFR-TK inhibitors. Mowafy S; Farag NA; Abouzid KA Eur J Med Chem; 2013 Mar; 61():132-45. PubMed ID: 23142066 [TBL] [Abstract][Full Text] [Related]
24. Discovery of novel 4-anilinoquinazoline derivatives as potent inhibitors of epidermal growth factor receptor with antitumor activity. Xu YY; Li SN; Yu GJ; Hu QH; Li HQ Bioorg Med Chem; 2013 Oct; 21(19):6084-91. PubMed ID: 23962660 [TBL] [Abstract][Full Text] [Related]
25. Discovery of new quinazolin-4(3H)-ones as VEGFR-2 inhibitors: Design, synthesis, and anti-proliferative evaluation. Eissa IH; El-Helby AA; Mahdy HA; Khalifa MM; Elnagar HA; Mehany ABM; Metwaly AM; Elhendawy MA; Radwan MM; ElSohly MA; El-Adl K Bioorg Chem; 2020 Dec; 105():104380. PubMed ID: 33128967 [TBL] [Abstract][Full Text] [Related]
26. Synthesis and Anti-Proliferative Evaluations of New Heterocyclic Derivatives Using 5,6,8,9-Tetrahydropyrazolo[5,1-b]quinazolin-7(3H)-one Derivatives Derived from Cyclohexa-1,4-dione. Mahmoud MAA; Alsharif MA; Mohareb RM Anticancer Agents Med Chem; 2021; 21(4):468-486. PubMed ID: 32445457 [TBL] [Abstract][Full Text] [Related]
27. Lemon Juice Mediated Synthesis of 3-Substituted Quinazolin-4(3H)-Ones and their Pharmacological Evaluation. Prasad MG; Lakshmi CV; Katari NK; Jonnalagadda SB; Pal M Anticancer Agents Med Chem; 2019; 19(16):2001-2009. PubMed ID: 31340741 [TBL] [Abstract][Full Text] [Related]
28. Design, synthesis and in vitro antitumor activity of novel N-substituted-4-phenyl/benzylphthalazin-1-ones. Eldehna WM; Ibrahim HS; Abdel-Aziz HA; Farrag NN; Youssef MM Eur J Med Chem; 2015 Jan; 89():549-60. PubMed ID: 25462265 [TBL] [Abstract][Full Text] [Related]
29. Synthesis, in vitro biological activities and in silico study of dihydropyrimidines derivatives. Barakat A; Islam MS; Al-Majid AM; Ghabbour HA; Fun HK; Javed K; Imad R; Yousuf S; Choudhary MI; Wadood A Bioorg Med Chem; 2015 Oct; 23(20):6740-8. PubMed ID: 26381063 [TBL] [Abstract][Full Text] [Related]
30. Design, synthesis and assessment of new series of quinazolinone derivatives as EGFR inhibitors along with their cytotoxic evaluation against MCF7 and A549 cancer cell lines. Aziz MW; Kamal AM; Mohamed KO; Elgendy AA Bioorg Med Chem Lett; 2021 Jun; 41():127987. PubMed ID: 33771586 [TBL] [Abstract][Full Text] [Related]
31. Design, synthesis and molecular docking of α,β-unsaturated cyclohexanone analogous of curcumin as potent EGFR inhibitors with antiproliferative activity. Xu YY; Cao Y; Ma H; Li HQ; Ao GZ Bioorg Med Chem; 2013 Jan; 21(2):388-94. PubMed ID: 23245570 [TBL] [Abstract][Full Text] [Related]
32. Synthesis and antitumor activities of some new N1-(flavon-6-yl)amidrazone derivatives. Habashneh AY; El-Abadelah MM; Zihlif MA; Imraish A; Taha MO Arch Pharm (Weinheim); 2014 Jun; 347(6):415-22. PubMed ID: 24615985 [TBL] [Abstract][Full Text] [Related]
33. DESIGN, SYNTHESIS AND BIOLOGICAL EVALUATION OF NEW PYRROLOAZEPINES WITH POTENTIAL AND SELECTIVE ANTITUMOR ACTIVITY. Jaiash DA; Belal A; Abdelgawad MA; Abdellatif KR Acta Pol Pharm; 2016; 73(2):359-68. PubMed ID: 27180428 [TBL] [Abstract][Full Text] [Related]
34. Molecular design and synthesis of certain new quinoline derivatives having potential anticancer activity. Ibrahim DA; Abou El Ella DA; El-Motwally AM; Aly RM Eur J Med Chem; 2015 Sep; 102():115-31. PubMed ID: 26256032 [TBL] [Abstract][Full Text] [Related]
35. Design, synthesis and evaluation of new quinazolin-4-one derivatives as apoptotic enhancers and autophagy inhibitors with potent antitumor activity. ElZahabi HSA; Nafie MS; Osman D; Elghazawy NH; Soliman DH; El-Helby AAH; Arafa RK Eur J Med Chem; 2021 Oct; 222():113609. PubMed ID: 34119830 [TBL] [Abstract][Full Text] [Related]
36. Design, synthesis, and docking studies of afatinib analogs bearing cinnamamide moiety as potent EGFR inhibitors. Tu Y; OuYang Y; Xu S; Zhu Y; Li G; Sun C; Zheng P; Zhu W Bioorg Med Chem; 2016 Apr; 24(7):1495-503. PubMed ID: 26906472 [TBL] [Abstract][Full Text] [Related]
37. 4-Substituted-1-phenyl-1H-pyrazolo[3,4-d]pyrimidine derivatives: design, synthesis, antitumor and EGFR tyrosine kinase inhibitory activity. Abbas SE; Aly EI; Awadallah FM; Mahmoud WR Chem Biol Drug Des; 2015 May; 85(5):608-22. PubMed ID: 25318985 [TBL] [Abstract][Full Text] [Related]
38. Design, synthesis, and biological evaluation of novel 3-substituted imidazo[1,2-a]pyridine and quinazolin-4(3H)-one derivatives as PI3Kα inhibitors. Fan YH; Li W; Liu DD; Bai MX; Song HR; Xu YN; Lee S; Zhou ZP; Wang J; Ding HW Eur J Med Chem; 2017 Oct; 139():95-106. PubMed ID: 28800461 [TBL] [Abstract][Full Text] [Related]
39. Design and synthesis of 4,6-substituted-(diaphenylamino)quinazolines as potent EGFR inhibitors with antitumor activity. Li HQ; Li DD; Lu X; Xu YY; Zhu HL Bioorg Med Chem; 2012 Jan; 20(1):317-23. PubMed ID: 22112541 [TBL] [Abstract][Full Text] [Related]
40. Design, Synthesis and Antitumor Activities of Novel Quinazolinone Derivatives as Potential EGFR Inhibitors. Wang J; Huang L; Chen X; Yuan Y; Sun J; Yang M Chem Pharm Bull (Tokyo); 2022; 70(9):637-641. PubMed ID: 36047235 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]